The SEC lists Neuronetics, Inc. under CIK 0001227636, in surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
STIM Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Open-market purchase
1
14,000
$44K
Open-market sale
1
100
$321
Grant or award
1
500,000
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
STIM insider transactions (Form 4)
42
57 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 1 of 2.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.13 tgo $3.17 rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests in four equal installments beginning on July 23, 2027, in each case subject to the Reporting Person's continuous employment with the Issuer through such date.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.79, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.36, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.59, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (price): The reported transactions involved a transfer of shares for no consideration between Madryn Health Partners II, LP ("Health Partners") and Madryn Health Partners II (Cayman Master), LP ("Cayman Master") for fund administration purposes.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.41, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (shares): The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full… Full note on SEC EDGAR
Footnote F1 (shares): The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full… Full note on SEC EDGAR
Footnote F1 (shares): The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full… Full note on SEC EDGAR
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.44, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.48, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (price): Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units.
Footnote F1 (price): Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units.
Footnote F1 (shares): Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 17, 2027, in each case subject to continuous service of the Reporting Person through such date.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F1 (price): The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.91 to $1.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any… Full note on SEC EDGAR
Footnote F1 (shares): The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.39 to $1.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full… Full note on SEC EDGAR
Footnote F1 (shares): The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full… Full note on SEC EDGAR
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
Neuronetics, Inc. (STIM) had 2 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for STIM runs to 57 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STIM stock?
1 insider purchase of STIM was filed in the last 90 days, totaling $44K.
How many insiders are selling STIM stock?
1 insider sale of STIM was filed in the last 90 days, totaling $321.
Where can I see STIM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STIM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Jorey Chernett - 10% OwnerOpen-market purchase$44K
Nir Naor - Officer
Avinash Amin
Daniel L. Reuvers - Officer
